Seeking Alpha


Send Message
View as an RSS Feed
View Teebonekrusher's Comments BY TICKER:
Latest  |  Highest rated
  • Drop The Anchor And Fish For Profits [View article]
    Steve, is that you now posting on stocktwits? Someone is using your name over there now. The picture they use doesn't match the picture used on SA. If it is in fact you, is that Michelle Caruso Cabrerra in the picture with you? If so, I am impressed!! Thank you very much for all of your efforts and contributions. They are greatly appreciated!!
    Oct 4, 2013. 03:26 PM | Likes Like |Link to Comment
  • AF Backtracking, AMRN Will Be Approved On Time [View instapost]
    I see where AF was taking another swipe at AMRN today. He is a horrible person who is rotten to the very core. Oh but wait, when his brother in law gets brain cancer he plays the humanitarian and begs his followers to donate money for his brother in law. Sugar wouldn't melt in his mouth when he is asking for handouts. I wonder if a drug that would be made available to treat his brother in law was being reviewed by an adcom if he would be singing a different tune. Well Vascepa could be made available to treat many people and all he does is root against it because management won't return his phone calls and his ego is bruised. Perhaps we should all be rooting against his brother in law. If Af was a nicer person I may have even made a donation, I did not.
    Sep 29, 2013. 12:12 PM | 3 Likes Like |Link to Comment
  • AF Backtracking, AMRN Will Be Approved On Time [View instapost]
    Adam, will you please let us know how many empty chairs there are at the adcom meeting? I remember you doing the same at a investor conference Amarin presented at some time ago. Those are the types of insights you offer which many of us find so meaningful.
    Sep 25, 2013. 10:05 PM | 3 Likes Like |Link to Comment
  • Explosive Bidding Situation Setting Up For Amarin [View instapost]
    Steve, I am a long time follower and first time poster. Would you please be so kind as to offer a few thoughts regarding the upcoming adcom. Do you see a possibility that the panel will be asked by the fda as whether or not reduce-it should run to completion before approval? Do you see the convening of a panel as more of a formality since this snda is for a never before approved indication in a large patient population? I am looking forward to any thoughts that you care to offer and the upcoming article. TIA!!!
    Sep 16, 2013. 08:37 PM | Likes Like |Link to Comment